Cyclacel

Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company developing oral therapies that target various phases of cell cycle control for the treatment of cancer and other serious diseases. Sir David Lane, a recognized leader in the field of tumor suppressor biology who discovered the p53 protein, founded the company in 1996. In 1999, Cyclacel Pharmaceuticals was joined by Professor David Glover, a recognized leader in mitosis or cellular mechanics. In addition to other cell cycle targets, mitotic kinases, Polo and Aurora, enzymes that function during the mitotic phase of the cell cycle, were discovered.